ZIOPHARM to Present at the Jefferies 2017 Global Healthcare Conference

BOSTON, June 02, 2017 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. ZIOP today announced that Laurence Cooper, M.D., Ph.D., Chief Executive Officer, will present at the Jefferies 2017 Global Healthcare Conference in New York on Friday, June 9, 2017 at 9:00 a.m. ET.

To access a live audio webcast of the presentation, please visit the Investor Relations section at www.ziopharm.com. The webcast will be archived for 90 days.

About ZIOPHARM Oncology, Inc.:

ZIOPHARM Oncology is a Boston, Massachusetts-based biotechnology company employing novel gene expression, control and cell technologies to deliver safe, effective and scalable cell- and viral-based therapies for the treatment of cancer and graft-versus-host-disease. The Company's immunotherapy programs, in collaboration with Intrexon Corporation XON, includes viral and non-viral approaches to deliver viral and cell-based therapeutic candidates for investigational treatment of liquid and solid tumors. The Company is advancing programs in multiple stages of development including Intrexon Corporation's RheoSwitch Therapeutic System^® technology, a switch to precisely modulate gene expression. The Company's pipeline includes adenoviral- and cell-based therapeutics in both clinical and preclinical testing, some of which are being advanced in collaboration with MD Anderson Cancer Center.

Contact:

David Pitts
Argot Partners
212-600-1902
david@argotpartners.com